Endovascular procedures in patients with Ehlers-Danlos syndrome: A review of clinical outcomes and iatrogenic complications

Ying Wei Lum, Benjamin S. Brooke, George J. Arnaoutakis, Timothy K. Williams, James Hamilton Black

Research output: Contribution to journalArticle

Abstract

Background: Ehlers-Danlos syndrome (EDS) is a hereditary connective tissue disorder caused by mutations in genes involved with collagen matrix formation that results in weakened blood vessels. Endovascular therapy on patients with EDS is fraught with concerns of vessel dissection and access site complications. We describe the technical and clinical outcomes of patients with EDS who have undergone a range of endovascular procedures. Methods: Patients with EDS undergoing endovascular procedures at a single-institution academic center between 1994 and 2010 were retrospectively reviewed. Perioperative data, including details of the procedure, hospital course, complications, and in-hospital mortality, were evaluated using nonparametric tests. Results: In all, 26 patients (8 with classic EDS, 15 with hypermobile EDS, and 3 with vascular EDS) who underwent 48 endovascular procedures (5 diagnostic, 43 interventional; 13 arterial, 35 venous) were identified. The indications for endovascular therapy included pelvic venous varices, visceral aneurysms/pseudoaneurysms, visceral/peripheral occlusive disease, coronary artery disease, and others. Median length of hospital stay was 2 days (range: 0-21 days). The rate of perioperative vascular injury and access site complications was low (2%), and it was not found to be associated with the type of vascular access technique, arterial versus venous procedures, target vessel site, sheath size, or method of closure (all: p > 0.1). Median follow-up period was 7.5 years. There were no late complications from the initial endovascular procedure. Conclusions: Certain endovascular procedures for patients with EDS can be safely performed with a low rate of dissections and access site complications. However, some indications (particularly aortic interventions) still remain to be determined.

Original languageEnglish (US)
Pages (from-to)25-33
Number of pages9
JournalAnnals of Vascular Surgery
Volume26
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

Ehlers-Danlos Syndrome
Endovascular Procedures
Blood Vessels
Dissection
Length of Stay
Vascular System Injuries
False Aneurysm
Varicose Veins
Hospital Mortality
Connective Tissue
Aneurysm
Coronary Artery Disease
Collagen
Mutation
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Endovascular procedures in patients with Ehlers-Danlos syndrome : A review of clinical outcomes and iatrogenic complications. / Lum, Ying Wei; Brooke, Benjamin S.; Arnaoutakis, George J.; Williams, Timothy K.; Black, James Hamilton.

In: Annals of Vascular Surgery, Vol. 26, No. 1, 01.2012, p. 25-33.

Research output: Contribution to journalArticle

@article{549e20b71bd74dc7840b38211a886fc1,
title = "Endovascular procedures in patients with Ehlers-Danlos syndrome: A review of clinical outcomes and iatrogenic complications",
abstract = "Background: Ehlers-Danlos syndrome (EDS) is a hereditary connective tissue disorder caused by mutations in genes involved with collagen matrix formation that results in weakened blood vessels. Endovascular therapy on patients with EDS is fraught with concerns of vessel dissection and access site complications. We describe the technical and clinical outcomes of patients with EDS who have undergone a range of endovascular procedures. Methods: Patients with EDS undergoing endovascular procedures at a single-institution academic center between 1994 and 2010 were retrospectively reviewed. Perioperative data, including details of the procedure, hospital course, complications, and in-hospital mortality, were evaluated using nonparametric tests. Results: In all, 26 patients (8 with classic EDS, 15 with hypermobile EDS, and 3 with vascular EDS) who underwent 48 endovascular procedures (5 diagnostic, 43 interventional; 13 arterial, 35 venous) were identified. The indications for endovascular therapy included pelvic venous varices, visceral aneurysms/pseudoaneurysms, visceral/peripheral occlusive disease, coronary artery disease, and others. Median length of hospital stay was 2 days (range: 0-21 days). The rate of perioperative vascular injury and access site complications was low (2{\%}), and it was not found to be associated with the type of vascular access technique, arterial versus venous procedures, target vessel site, sheath size, or method of closure (all: p > 0.1). Median follow-up period was 7.5 years. There were no late complications from the initial endovascular procedure. Conclusions: Certain endovascular procedures for patients with EDS can be safely performed with a low rate of dissections and access site complications. However, some indications (particularly aortic interventions) still remain to be determined.",
author = "Lum, {Ying Wei} and Brooke, {Benjamin S.} and Arnaoutakis, {George J.} and Williams, {Timothy K.} and Black, {James Hamilton}",
year = "2012",
month = "1",
doi = "10.1016/j.avsg.2011.05.028",
language = "English (US)",
volume = "26",
pages = "25--33",
journal = "Annals of Vascular Surgery",
issn = "0890-5096",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Endovascular procedures in patients with Ehlers-Danlos syndrome

T2 - A review of clinical outcomes and iatrogenic complications

AU - Lum, Ying Wei

AU - Brooke, Benjamin S.

AU - Arnaoutakis, George J.

AU - Williams, Timothy K.

AU - Black, James Hamilton

PY - 2012/1

Y1 - 2012/1

N2 - Background: Ehlers-Danlos syndrome (EDS) is a hereditary connective tissue disorder caused by mutations in genes involved with collagen matrix formation that results in weakened blood vessels. Endovascular therapy on patients with EDS is fraught with concerns of vessel dissection and access site complications. We describe the technical and clinical outcomes of patients with EDS who have undergone a range of endovascular procedures. Methods: Patients with EDS undergoing endovascular procedures at a single-institution academic center between 1994 and 2010 were retrospectively reviewed. Perioperative data, including details of the procedure, hospital course, complications, and in-hospital mortality, were evaluated using nonparametric tests. Results: In all, 26 patients (8 with classic EDS, 15 with hypermobile EDS, and 3 with vascular EDS) who underwent 48 endovascular procedures (5 diagnostic, 43 interventional; 13 arterial, 35 venous) were identified. The indications for endovascular therapy included pelvic venous varices, visceral aneurysms/pseudoaneurysms, visceral/peripheral occlusive disease, coronary artery disease, and others. Median length of hospital stay was 2 days (range: 0-21 days). The rate of perioperative vascular injury and access site complications was low (2%), and it was not found to be associated with the type of vascular access technique, arterial versus venous procedures, target vessel site, sheath size, or method of closure (all: p > 0.1). Median follow-up period was 7.5 years. There were no late complications from the initial endovascular procedure. Conclusions: Certain endovascular procedures for patients with EDS can be safely performed with a low rate of dissections and access site complications. However, some indications (particularly aortic interventions) still remain to be determined.

AB - Background: Ehlers-Danlos syndrome (EDS) is a hereditary connective tissue disorder caused by mutations in genes involved with collagen matrix formation that results in weakened blood vessels. Endovascular therapy on patients with EDS is fraught with concerns of vessel dissection and access site complications. We describe the technical and clinical outcomes of patients with EDS who have undergone a range of endovascular procedures. Methods: Patients with EDS undergoing endovascular procedures at a single-institution academic center between 1994 and 2010 were retrospectively reviewed. Perioperative data, including details of the procedure, hospital course, complications, and in-hospital mortality, were evaluated using nonparametric tests. Results: In all, 26 patients (8 with classic EDS, 15 with hypermobile EDS, and 3 with vascular EDS) who underwent 48 endovascular procedures (5 diagnostic, 43 interventional; 13 arterial, 35 venous) were identified. The indications for endovascular therapy included pelvic venous varices, visceral aneurysms/pseudoaneurysms, visceral/peripheral occlusive disease, coronary artery disease, and others. Median length of hospital stay was 2 days (range: 0-21 days). The rate of perioperative vascular injury and access site complications was low (2%), and it was not found to be associated with the type of vascular access technique, arterial versus venous procedures, target vessel site, sheath size, or method of closure (all: p > 0.1). Median follow-up period was 7.5 years. There were no late complications from the initial endovascular procedure. Conclusions: Certain endovascular procedures for patients with EDS can be safely performed with a low rate of dissections and access site complications. However, some indications (particularly aortic interventions) still remain to be determined.

UR - http://www.scopus.com/inward/record.url?scp=84155171304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84155171304&partnerID=8YFLogxK

U2 - 10.1016/j.avsg.2011.05.028

DO - 10.1016/j.avsg.2011.05.028

M3 - Article

C2 - 21945330

AN - SCOPUS:84155171304

VL - 26

SP - 25

EP - 33

JO - Annals of Vascular Surgery

JF - Annals of Vascular Surgery

SN - 0890-5096

IS - 1

ER -